Grail (GRAL) | Stock Overview & Key Data
Grail Performance Comparison
Stock Range
Today's Range
Low: $64.13
High: $73.74
on October 3, 2025
52 Week Range
Low: $12.33
High: $73.74
on October 7, 2024
on October 3, 2025
All-Time High: $73.74 on October 3, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$2.4B
EPS
-11.71
P/E Ratio (TTM)
-1.03
Forward P/E
-5.58
P/B Ratio
1.02
PEG Ratio
0.01
Div. Yield
N/A
ROE
-17.68%
Beta
N/A
Debt to Equity
2.69
Financial Highlights
Profitability
Gross Margin
-50.01%
Operating Margin
-368.15%
Profit Margin
-62.12%
Returns and Earnings
Return on Assets (TTM)
-11.81%
Return on Equity (TTM)
-17.68%
EBITDA
$810.8M
Net Income (TTM)
$-443.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$3.96
Quarterly Revenue Growth (YoY)
11.20%
Quarterly Earnings Growth (YoY)
11.18%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Grail GRAL | 2.36B Mid-cap | 31.45% | 102.16% | 40.28% | 163.42% | 265.74% | 402.99% | 348.29% | 348.29% |
| Thermo Fisher TMO | 206.14B Mega-cap | 17.03% | 12.13% | 26.55% | 15.59% | 3.97% | -9.24% | 3.76% | 16.92% |
| Danaher DHR | 153.94B Large-cap | 16.31% | 7.80% | 5.80% | 8.64% | -6.45% | -20.38% | -9.67% | 7.28% |
| Charles River CRL | 8.82B Mid-cap | 19.37% | 9.24% | 12.86% | 25.78% | -2.91% | -7.03% | -13.64% | -26.90% |
| Guardant Health GH | 7.84B Mid-cap | 4.68% | -3.41% | 24.44% | 49.55% | 97.80% | 183.57% | 12.72% | -41.92% |
| RadNet RDNT | 6.07B Mid-cap | 2.28% | 9.43% | 38.15% | 56.82% | 10.68% | 13.06% | 308.85% | 359.41% |
Ownership & Short Interest
Insider Ownership
13.81%
Institutional Ownership
73.55%
Shares Short
4M
Short Ratio
6.44
Short % of Shares Outstanding
14.29%
Average 10-Day Volume
1M
Average 90-Day Volume
879K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is GRAL's 52-week high and low?
- In the last 52 weeks, Grail reached a high of $73.74 (on October 3, 2025) and a low of $12.33 (on October 7, 2024).
- What is the market cap and P/E ratio for GRAL?
- Curious about Grail's size and valuation? Its market capitalization stands at 2.36B. When it comes to valuation, the P/E ratio (trailing twelve months) is -1.03, and the forward P/E (looking ahead) is -5.58.
- Does GRAL pay dividends? If so, what's the yield?
- As for dividends, Grail isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Grail's main competitors or similar companies to consider before investing?
When looking at Grail, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO206.14B Healthcare Diagnostics & Research -9.24% 3.76% Danaher
DHR153.94B Healthcare Diagnostics & Research -20.38% -9.67% Charles River
CRL8.82B Healthcare Diagnostics & Research -7.03% -13.64% Guardant Health
GH7.84B Healthcare Diagnostics & Research 183.57% 12.72% RadNet
RDNT6.07B Healthcare Diagnostics & Research 13.06% 308.85% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Grail Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Grail's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -17.68%, the Debt to Equity ratio from the most recent quarter is 2.69, and its Gross Profit Margin stands at -50.01%.
- What is the recent revenue and earnings growth for GRAL?
- Looking at Grail's growth, its revenue over the trailing twelve months (TTM) was $134M. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.20%, and quarterly earnings saw a YoY growth of 11.18%.
- How much of GRAL stock is held by insiders and institutions?
- Wondering who owns Grail stock? Company insiders (like executives and directors) hold about 13.81% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 73.55%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.